Clinical Trials Browser

Phase 1 × Stomach Neoplasms × Folfox protocol × Clear all

NCT03597581 2025-04-03

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms